8,200 Shares in Encompass Health Corporation $EHC Bought by ING Groep NV

ING Groep NV bought a new stake in Encompass Health Corporation (NYSE:EHC) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 8,200 shares of the company’s stock, valued at approximately $1,042,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. MQS Management LLC bought a new position in Encompass Health in the 3rd quarter valued at approximately $526,000. Navellier & Associates Inc. acquired a new position in Encompass Health in the 3rd quarter valued at approximately $203,000. Johnson Investment Counsel Inc. bought a new position in shares of Encompass Health during the third quarter valued at $284,000. Linden Thomas Advisory Services LLC lifted its holdings in shares of Encompass Health by 2.8% during the third quarter. Linden Thomas Advisory Services LLC now owns 15,461 shares of the company’s stock worth $1,964,000 after purchasing an additional 416 shares during the period. Finally, Smartleaf Asset Management LLC grew its stake in shares of Encompass Health by 16.1% in the third quarter. Smartleaf Asset Management LLC now owns 1,607 shares of the company’s stock worth $202,000 after purchasing an additional 223 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages recently issued reports on EHC. Raymond James Financial raised Encompass Health to a “strong-buy” rating in a research report on Friday, October 31st. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, January 18th. Barclays upped their target price on Encompass Health from $150.00 to $153.00 and gave the company an “overweight” rating in a report on Friday, February 6th. Finally, Zacks Research lowered shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. Two investment analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $143.29.

Insider Buying and Selling

In other news, CEO Mark J. Tarr sold 150,000 shares of the company’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $111.64, for a total transaction of $16,746,000.00. Following the transaction, the chief executive officer owned 377,070 shares in the company, valued at approximately $42,096,094.80. This represents a 28.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 2.00% of the company’s stock.

Encompass Health Trading Down 1.8%

NYSE EHC opened at $110.02 on Friday. The stock has a market capitalization of $11.07 billion, a P/E ratio of 19.86, a P/E/G ratio of 2.10 and a beta of 0.73. The business has a 50 day simple moving average of $103.93 and a 200 day simple moving average of $114.54. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.08 and a quick ratio of 1.14. Encompass Health Corporation has a one year low of $92.53 and a one year high of $127.99.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, February 5th. The company reported $1.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.29 by $0.17. The firm had revenue of $3.09 billion for the quarter, compared to analysts’ expectations of $1.54 billion. Encompass Health had a return on equity of 18.20% and a net margin of 9.54%.The company’s revenue for the quarter was up 9.9% compared to the same quarter last year. During the same period in the prior year, the business earned $1.17 EPS. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. Research analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current year.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.